Skip to main content

Table 2 Comparison between the two studied groups according to different tumor markers

From: Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients

  Group A (n = 40) Group B (n = 40) U p
AFP (ng/ml)
 Min–max 1.0–51.0 1.10–589.0 291.50* < 0.001*
 Mean ± SD 8.85 ± 14.51 90.49 ± 132.65
 Median 3.85 0.0
OPN (ng/ml)
 Min–max 5.10–29.30 6.10–80.40 417.0* < 0.001*
 Mean ± SD 11.08 ± 4.20 22.87 ± 19.31
 Median 10.30 16.10
ANXA2 (ng/ml)
 Min–max 5.40–16.60 8.90–40.80 116.50* < 0.001*
 Mean ± SD 8.34 ± 2.34 14.98 ± 5.93
 Median 8.05 13.45
  1. U Mann Whitney test
  2. p p value for comparing between the studied groups
  3. *Statistically significant at p ≤ 0.05